J. Martin et al., EFFECTS OF THE RIBAVIRIN INTERFERON-ALPHA COMBINATION ON CULTURED PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM CHRONIC HEPATITIS-C PATIENTS, Cytokine (Philadelphia, Pa. Print), 10(8), 1998, pp. 635-644
The effects of ribavirin and interferon (IFN) alpha have been investig
ated on cultured peripheral blood mononuclear cells, obtained from 15
patients with chronic hepatitis C virus (HCV) infection. At clinically
relevant serum concentrations achieved during therapeutic administrat
ion, ribavirin did inhibit moderately the mitogen-stimulated mononucle
ar cell proliferation and growth of the CD4(+) and CD8(+) T cell subse
ts without apparent cytolysis, The ribavirin-IFN-alpha combination sho
wed activity against HCV with disappearance of HCV RNA in 27% of cases
, and a synergy in the inducibility of the intracellular enzyme 2',5'-
oligoadenylate synthetase, Such ribavirin concentrations induced modes
t increases in the T helper 1-like cytokine production by mononuclear
cells. Higher ribavirin concentrations markedly inhibited IFN-gamma pr
oduction, but augmented interleukins (IL) 2, 4, and 12 secretion. Conv
ersely, IFN-alpha tended to suppress IL 2, 4 and 12, but enhanced IFN-
gamma and IL-10 secretion. Thus, ribavirin and IFN-alpha appear to cau
se diverse effects on immunoregulatory cytokine secretion, and when co
mbined, counteracted for production of IL-2 and IL-12, while upregulat
ed mononuclear cell secretion of IFN-gamma and that of the anti-inflam
matory cytokine IL-10, These findings suggest a non-cytolytic modulati
on of inflammatory responses induced by the drug combination, that may
be relevant in the pathophysiology of chronic HCV infection. (C) 1998
Academic Press.